A Case Report on Postpartum Hellp Syndrome with Septic Shock and Multi-Organ Failure
Abstract
This case study presents a 25-year-old female patient who developed severe complications post-lower segment cesarean section (LSCS), characterized by decreased urine output, jaundice, confusion, shortness of breath, and fever. Her clinical history included pedal edema and confusion, with notable laboratory findings indicating metabolic acidosis, hyperkalemia, elevated liver enzymes, thrombocytopenia, and acute kidney dysfunction, suggesting HELLP syndrome complicated by septic shock and multi-organ dysfunction syndrome (MODS). Despite aggressive interventions, including vasopressors, dialysis, intubation, and broad-spectrum antibiotics, the patient's condition rapidly deteriorated, leading to cardiac arrest and subsequent death. This case underscores the critical need for early recognition and comprehensive management of HELLP syndrome and sepsis in postpartum patients, emphasizing the importance of multidisciplinary care and continuous monitoring to improve maternal outcomes. The findings highlight the potentially fatal nature of these conditions and the imperative for vigilance in the postpartum period.
References
2. Singer M, Deutschman CS, Seymour CW. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA [Internet]. 2016 Feb 23;315(8):801–10.
3. García-Álvarez R, Arboleda-Salazar R. Vasopressin in Sepsis and Other Shock States: State of the Art. Journal of Personalized Medicine [Internet]. 2023 Nov 1 [cited 2023 Nov 6];13(11):1548.
4. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care [Internet]. 2007 [cited 2019 Nov 28];11(2):R31.
5. Sarode R, Bandarenko N, Brecher ME, Kiss JE, Marques MB, Szczepiorkowski ZM, et al. Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. Journal of Clinical Apheresis. 2013 Oct 17;29(3):148–67.
6. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. The Lancet. 2010 Feb;375(9714):594–605.
7. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). American Journal of Obstetrics and Gynecology. 1993 Oct;169(4):1000–6.
8. Neuhaus W, Crombach G, Hamm W, Bolte A. A case of HELLP syndrome at 23 weeks’ gestation. Archives of Gynecology and Obstetrics. 1994 Dec;255(4):217–9.
9. von Auer C, von Krogh AS, Kremer Hovinga JA, Lämmle B. Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy. Thrombosis Research. 2015 Feb;135:S30–3.
10. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. American Journal of Obstetrics and Gynecology. 1986 Sep;155(3):501–7.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors Retained the Copyright Policy

.